MICHELLE L ODONOGHUE

Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease BOSTON, MA NPI 1326085366

General Payments — all program years on this page

$83,594.09

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 60
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $19,142.02 across 17 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Amgen Inc. $9,671.0211
Janssen Research & Development, LLC $7,860.005
AstraZeneca UK Limited $1,611.001

By program year

Program yearAmountRecords
2018 $4,831.883
2019 $4,143.295
2020 $18,690.8617
2021 $10,261.005
2022 $8,177.985
2023 $18,347.068
2024 $19,142.0217

Records — PY2024 (17)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1077588023 Janssen Research & Development, LLC $50.00 08/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1077588061 Janssen Research & Development, LLC $60.00 04/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1077590253 Janssen Research & Development, LLC $1,750.00 02/07/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1077590255 Janssen Research & Development, LLC $3,500.00 09/17/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1077590257 Janssen Research & Development, LLC $2,500.00 04/18/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1093888921 AstraZeneca UK Limited $1,611.00 07/24/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1115978104 Amgen Inc. $3,000.00 07/15/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1115978111 Amgen Inc. $53.80 07/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115978116 Amgen Inc. $62.00 07/18/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1115978122 Amgen Inc. $534.54 05/30/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1115978129 Amgen Inc. $3,570.00 10/23/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1117644287 Amgen Inc. $2,262.00 04/16/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1117644289 Amgen Inc. $15.00 11/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117644291 Amgen Inc. $15.00 11/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117644293 Amgen Inc. $54.04 08/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117644295 Amgen Inc. $55.70 09/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117644297 Amgen Inc. $48.94 04/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.